Clinical Trials Logo
  1. Home
  2. Alcohol Withdrawal Syndrome
  3. NCT00146471

Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome

Alcohol Withdrawal Syndrome Clinical Trial

Official title:
Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [Sicherheit Und Wirksamkeit Von Levetiracetam (Keppra) für Die Behandlung Des stationären Alkoholentzugsyndroms]

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of levetiracetam for treating alcohol withdrawal syndrome (AWS) in inpatients (vs. placebo). The primary come-out parameter is the reduction of the total needed amount of diazepam for add-on treatment of acute alcohol withdrawal symptoms. The secondary come-out parameter are - safety criteria (AE) - reduction of alcohol withdrawal score over the days.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00146471
Study type Interventional
Source Charite University, Berlin, Germany
Contact
Status Completed
Phase Phase 3
Start date January 2006
Completion date September 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT03033823 - MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA) Phase 3
Completed NCT02146716 - Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms. N/A
Completed NCT01637415 - The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS) N/A
Completed NCT04973202 - Portrayal of Hospital Alcohol Detoxification in France
Terminated NCT02052440 - Preventing Alcohol Withdrawal Syndrome With Oral Baclofen Phase 3
Completed NCT01652326 - Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome N/A
Recruiting NCT03235531 - Assessment of Valproate on Ethanol Withdrawal Phase 4
Completed NCT02090504 - Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome Phase 4
Completed NCT03012815 - Gabapentin for Alcohol Withdrawal Syndrome Phase 4
Completed NCT05438641 - Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants
Completed NCT00249366 - Treatment of Alcohol Withdrawal in Hospital Patients Phase 4
Withdrawn NCT03788889 - Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine Phase 4